Coloplast A/S (OTCMKTS:CLPBY) Announces Earnings Results, Beats Estimates By $0.01 EPS

Coloplast A/S (OTCMKTS:CLPBY) announced its earnings results on Tuesday. The company reported $0.10 EPS for the quarter, beating analysts’ consensus estimates of $0.09 by $0.01, Zacks reports. Coloplast A/S had a return on equity of 27.87% and a net margin of 14.35%.

Coloplast A/S Stock Performance

Shares of CLPBY opened at $6.43 on Wednesday. The stock has a 50-day simple moving average of $6.74 and a 200-day simple moving average of $7.98. The company has a debt-to-equity ratio of 1.50, a quick ratio of 0.81 and a current ratio of 1.30. The stock has a market capitalization of $14.49 billion, a PE ratio of 23.82, a PEG ratio of 2.04 and a beta of 0.15. Coloplast A/S has a 1 year low of $6.10 and a 1 year high of $10.03.

Analysts Set New Price Targets

CLPBY has been the subject of several recent research reports. The Goldman Sachs Group lowered shares of Coloplast A/S from a “hold” rating to a “strong sell” rating in a research note on Tuesday, April 7th. Sanford C. Bernstein raised shares of Coloplast A/S to a “hold” rating in a research note on Wednesday, January 28th. One analyst has rated the stock with a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, Coloplast A/S currently has an average rating of “Reduce”.

About Coloplast A/S

Coloplast A/S is a global developer and manufacturer of medical devices and services focused on intimate healthcare. The company specializes in solutions designed to assist individuals with chronic medical conditions, aiming to improve quality of life through innovative products. Coloplast’s offerings span ostomy care, continence care, wound and skin care, and interventional urology, targeting patients who require long-term support and specialized treatments.

In its ostomy business, Coloplast provides pouches, skin barriers and accessories for patients who have had surgical procedures to divert bodily waste.